InterCure Congratulates Germany on Cannabis Reform, Expanding its Global FootprintBusiness Wire • 03/22/24
PESG Industry Updates: Germany's Cannabis Act and Its Impact on the Medical Cannabis LandscapeBusiness Wire • 02/23/24
InterCure Announces Record Revenues First Half of 2023 with over 14% growth YOYGlobeNewsWire • 08/31/23
InterCure Ltd. Announces Proposed Voluntary Delisting from the Toronto Stock Exchange and shall continue to be listed on the NASDAQ and TASEGlobeNewsWire • 07/10/23
InterCure Provides an Update About The Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed MergerGlobeNewsWire • 06/09/23
InterCure to Participate in the Cowen 3rd Annual European Cannabis ConferenceGlobeNewsWire • 05/15/23
InterCure Announces Record Breaking First Quarter Revenues with 22% growth YOYGlobeNewsWire • 05/15/23
InterCure Informs That A Lawsuit Was Filed Against the Company by Minority Shareholders of Its SubsidiaryGlobeNewsWire • 04/25/23
InterCure Informs That An Application To Approve a Class Action Against 26 Cannabis Companies in Israel, Including InterCure, Was Filed to The Court In IsraelGlobeNewsWire • 04/24/23
InterCure Ltd. Partners with TYSON 2.0 in Israel, Australia, United Kingdom, Germany and Other EU CountriesGlobeNewsWire • 04/20/23
InterCure Files Lawsuit Against Cann Pharmaceuticals to Recover Funds Following Failed MergerGlobeNewsWire • 02/14/23
InterCure Announces the Termination of its Acquisition Agreement with Cann Pharmaceutical (dba Better)GlobeNewsWire • 02/01/23
InterCure Announces Exclusive International Partnership Agreement with Award Winning Cannabis Brand "Binske"GlobeNewsWire • 12/19/22